Insider Transactions Reported by 13 Insiders of Forte Biosciences, Inc.

Symbol
FBRX on Nasdaq
Location
Dallas, TX

Insiders trading volume in the past year

Forte Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ph.D. Paul A. Wagner CEO, Secretary and Chair of the Board, Director $2,466,977 12 Jan 2026
Antony A. Riley Chief Financial Officer $1,157,781 +$254,833 +28% 12 Jan 2026
Hubert C. Chen President and Chief Scientific Officer $150,704 01 Jan 2024
Donald Allen Williams Director 20 Aug 2024
Stephen K. Doberstein Director 20 Mar 2025
Steven Kornfeld Director 20 Mar 2025
Shivpreet Singh Kapoor Director 20 Mar 2025
Lawrence Eichenfield Director 20 Aug 2024
BARBARA K. FINCK Director 19 Mar 2025
Scott C. Brun Director 20 Mar 2025
DAVID W. GRYSKA Director 20 Mar 2025
Patricia S. Walker Director 01 Jun 2022
RICHARD G. VINCENT Director 20 Mar 2025

Recent Insider Transactions by Companies or Individuals for Forte Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.